1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

C162H199B3Br2F4N26O26 — CID 158282816

IUPAC1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESC=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@H](C(=O)Nc4nc(C)ccc4C)C[C@@]4(CNC(=O)C(F)(F)C=CCCCCC)C[C@@H]34)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)O)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(B2OC(C)(C)C(C)(C)O2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(Br)cc2c(C(C)=O)nn(CC(C)=O)c12.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCCCCC=CC(F)(F)C(=O)NC[C@@]12C[C@@H](C(=O)Nc3nc(C)ccc3C)N[C@@H]1C2.Cc1ncc(Br)cn1
InChIInChI=1S/C43H50F2N8O5.C23H32F2N4O2.C22H29BN2O5.C21H22N4O3.C20H20N4O4.C16H17BrN2O3.C12H24B2O4.C5H5BrN2/c1-7-9-10-11-12-15-43(44,45)41(57)48-25-42-19-34(40(56)50-39-26(3)13-14-27(4)49-39)53(35(42)20-42)36(55)23-52-38-31(24-58-16-8-2)17-30(32-21-46-29(6)47-22-32)18-33(38)37(51-52)28(5)54;1-4-5-6-7-8-11-23(24,25)21(31)26-14-22-12-17(28-18(22)13-22)20(30)29-19-15(2)9-10-16(3)27-19;1-8-9-28-13-16-10-17(23-29-21(4,5)22(6,7)30-23)11-18-19(15(3)27)24-25(20(16)18)12-14(2)26;1-5-6-28-12-17-7-16(18-9-22-15(4)23-10-18)8-19-20(14(3)27)24-25(21(17)19)11-13(2)26;1-4-5-28-11-15-6-14(16-8-21-13(3)22-9-16)7-17-19(12(2)25)23-24(20(15)17)10-18(26)27;1-4-5-22-9-12-6-13(17)7-14-15(11(3)21)18-19(16(12)14)8-10(2)20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-4-7-2-5(6)3-8-4/h8,12-15,17-18,21-22,34-35H,2,7,9-11,16,19-20,23-25H2,1,3-6H3,(H,48,57)(H,49,50,56);8-11,17-18,28H,4-7,12-14H2,1-3H3,(H,26,31)(H,27,29,30);8,10-11H,1,9,12-13H2,2-7H3;5,7-10H,1,6,11-12H2,2-4H3;4,6-9H,1,5,10-11H2,2-3H3,(H,26,27);4,6-7H,1,5,8-9H2,2-3H3;1-8H3;2-3H,1H3/t34-,35+,42-;17-,18+,22-;;;;;;/m00....../s1
InChIKeyGKKKVVUCMQLELE-XTNCEVGASA-N
MW3194.77 g/mol
LogP26.26
Rot. Bonds60

About 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 158282816) has the molecular formula C162H199B3Br2F4N26O26 and a molecular weight of 3194.77 g/mol. Its IUPAC name is 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

Molecular Properties

Compound Name1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
PubChem CID158282816
Molecular FormulaC162H199B3Br2F4N26O26
Molecular Weight3194.77 g/mol
Exact Mass3191.36
IUPAC Name1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESC=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@H](C(=O)Nc4nc(C)ccc4C)C[C@@]4(CNC(=O)C(F)(F)C=CCCCCC)C[C@@H]34)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)O)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(B2OC(C)(C)C(C)(C)O2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(Br)cc2c(C(C)=O)nn(CC(C)=O)c12.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCCCCC=CC(F)(F)C(=O)NC[C@@]12C[C@@H](C(=O)Nc3nc(C)ccc3C)N[C@@H]1C2.Cc1ncc(Br)cn1
InChIInChI=1S/C43H50F2N8O5.C23H32F2N4O2.C22H29BN2O5.C21H22N4O3.C20H20N4O4.C16H17BrN2O3.C12H24B2O4.C5H5BrN2/c1-7-9-10-11-12-15-43(44,45)41(57)48-25-42-19-34(40(56)50-39-26(3)13-14-27(4)49-39)53(35(42)20-42)36(55)23-52-38-31(24-58-16-8-2)17-30(32-21-46-29(6)47-22-32)18-33(38)37(51-52)28(5)54;1-4-5-6-7-8-11-23(24,25)21(31)26-14-22-12-17(28-18(22)13-22)20(30)29-19-15(2)9-10-16(3)27-19;1-8-9-28-13-16-10-17(23-29-21(4,5)22(6,7)30-23)11-18-19(15(3)27)24-25(20(16)18)12-14(2)26;1-5-6-28-12-17-7-16(18-9-22-15(4)23-10-18)8-19-20(14(3)27)24-25(21(17)19)11-13(2)26;1-4-5-28-11-15-6-14(16-8-21-13(3)22-9-16)7-17-19(12(2)25)23-24(20(15)17)10-18(26)27;1-4-5-22-9-12-6-13(17)7-14-15(11(3)21)18-19(16(12)14)8-10(2)20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-4-7-2-5(6)3-8-4/h8,12-15,17-18,21-22,34-35H,2,7,9-11,16,19-20,23-25H2,1,3-6H3,(H,48,57)(H,49,50,56);8-11,17-18,28H,4-7,12-14H2,1-3H3,(H,26,31)(H,27,29,30);8,10-11H,1,9,12-13H2,2-7H3;5,7-10H,1,6,11-12H2,2-4H3;4,6-9H,1,5,10-11H2,2-3H3,(H,26,27);4,6-7H,1,5,8-9H2,2-3H3;1-8H3;2-3H,1H3/t34-,35+,42-;17-,18+,22-;;;;;;/m00....../s1
InChIKeyGKKKVVUCMQLELE-XTNCEVGASA-N
XLogP26.26
TPSA642.13 Ų
H-Bond Donors6
H-Bond Acceptors46
Rotatable Bonds60
Heavy Atoms223
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003194.77
LogP ≤ 526.26
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1046

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The IUPAC name of 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 158282816) is 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
What is the SMILES notation for 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The canonical SMILES for 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@H](C(=O)Nc4nc(C)ccc4C)C[C@@]4(CNC(=O)C(F)(F)C=CCCCCC)C[C@@H]34)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)O)c12.C=CCOCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(B2OC(C)(C)C(C)(C)O2)cc2c(C(C)=O)nn(CC(C)=O)c12.C=CCOCc1cc(Br)cc2c(C(C)=O)nn(CC(C)=O)c12.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CCCCCC=CC(F)(F)C(=O)NC[C@@]12C[C@@H](C(=O)Nc3nc(C)ccc3C)N[C@@H]1C2.Cc1ncc(Br)cn1.
What is the InChIKey of 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The InChIKey is GKKKVVUCMQLELE-XTNCEVGASA-N. The full InChI is InChI=1S/C43H50F2N8O5.C23H32F2N4O2.C22H29BN2O5.C21H22N4O3.C20H20N4O4.C16H17BrN2O3.C12H24B2O4.C5H5BrN2/c1-7-9-10-11-12-15-43(44,45)41(57)48-25-42-19-34(40(56)50-39-26(3)13-14-27(4)49-39)53(35(42)20-42)36(55)23-52-38-31(24-58-16-8-2)17-30(32-21-46-29(6)47-22-32)18-33(38)37(51-52)28(5)54;1-4-5-6-7-8-11-23(24,25)21(31)26-14-22-12-17(28-18(22)13-22)20(30)29-19-15(2)9-10-16(3)27-19;1-8-9-28-13-16-10-17(23-29-21(4,5)22(6,7)30-23)11-18-19(15(3)27)24-25(20(16)18)12-14(2)26;1-5-6-28-12-17-7-16(18-9-22-15(4)23-10-18)8-19-20(14(3)27)24-25(21(17)19)11-13(2)26;1-4-5-28-11-15-6-14(16-8-21-13(3)22-9-16)7-17-19(12(2)25)23-24(20(15)17)10-18(26)27;1-4-5-22-9-12-6-13(17)7-14-15(11(3)21)18-19(16(12)14)8-10(2)20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-4-7-2-5(6)3-8-4/h8,12-15,17-18,21-22,34-35H,2,7,9-11,16,19-20,23-25H2,1,3-6H3,(H,48,57)(H,49,50,56);8-11,17-18,28H,4-7,12-14H2,1-3H3,(H,26,31)(H,27,29,30);8,10-11H,1,9,12-13H2,2-7H3;5,7-10H,1,6,11-12H2,2-4H3;4,6-9H,1,5,10-11H2,2-3H3,(H,26,27);4,6-7H,1,5,8-9H2,2-3H3;1-8H3;2-3H,1H3/t34-,35+,42-;17-,18+,22-;;;;;;/m00....../s1.
What are the key properties of 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 3194.77 g/mol, XLogP of 26.26, 60 rotatable bonds, 6 hydrogen bond donors, and 46 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-acetyl-5-bromo-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetic acid;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]acetyl]-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;1-[3-acetyl-5-(2-methylpyrimidin-5-yl)-7-(prop-2-enoxymethyl)indazol-1-yl]propan-2-one;1-[3-acetyl-7-(prop-2-enoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]propan-2-one;5-bromo-2-methylpyrimidine;(1R,3S,5R)-5-[(2,2-difluoronon-3-enoylamino)methyl]-N-(3,6-dimethyl-2-pyridinyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 158282816), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).